Abstract
This chapter describes methods of preparation of nanospheres and nanocapsules by polymerization giving advises to carry on the polymerization reactions to produce nanoparticles with well-defined characteristics. The number one polymer that composes nanoparticles prepared by polymerization in the aim to use them as drug carrier is poly(alkylcyanoacrylate) (PACA). A comprehensive view of the polymerization reactions of the corresponding monomer is given considering the conditions that are applied to produce the nanoparticles. It is then explained how to prepare PACA nanospheres by emulsion polymerization and oil- and water containing PACA nanocapsules by interfacial polymerization of these monomers and how to play with the reaction conditions to give the nanoparticles the desired characteristics. Besides nanoparticles made of PACA, nanocapsules with envelopes composed of polyurethane, polyamide, and polyesters can be synthesized by interfacial polycondensation methods carried out in very thin emulsions. This method will be described at the end of the chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aboubakar M, Puisieux F, Couvreur P, Deyme M, Vauthier C (1999) Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. J Biomed Mater Res 47:568–576
Al Khouri Fallouh N, Roblot Treupel L, Fessi H, Devissaguet JP, Puisieux F (1986) Development of a new process for manufacture of polyisobutylcyanoacrylate nanocapsules. Int J Pharm 28:125–132
Al-Mubarak L, Al-Haddab M (2013) Cutaneous wound closure materials: an overview and update. J Cutan Aesthet Surg 6(4):178–188. doi:10.4103/0974-2077.123395
Alhareth K, Vauthier C, Bourasset F, Gueutin C, Ponchel G, Moussa F (2012) Conformation of surface-decorating dextran chains affects the pharmacokinetics and biodistribution of doxorubicin-loaded nanoparticles. Eur J Pharm Biopharm 81:453–457. doi:10.1016/j.ejpb.2012.03.009
Alhareth K, Vauthier C, Gueutin C, Ponchel G, Moussa F (2011) Doxorubicin loading and in vitro release from poly(alkylcyanoacrylate) nanoparticles produced by redox radical emulsion polymerization. J Appl Polym Sci 119:816–822. doi:10.1002/app.32789
Altinbas N, Fehmer C, Terheiden A, Shukla A, Rehage H, Mayer C (2006) Alkylcyanoacrylate nanocapsules prepared from mini-emulsions: a comparison with the conventional approach. J Microencapsul 23:567–581
Andrieux K, Couvreur P (2009) Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:463–474. doi:10.1002/wnan.5
Behan N, Birkinshaw C, Clarke N (2001) Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation. Biomaterials 22:1335–1344
Bertholon I, Lesieur S, Labarre D, Besnard M, Vauthier C (2006a) Characterization of dextran-poly(isobutylcyanoacrylate) copolymers obtained by redox radical and anionic emulsion polymerization. Macromolecules 39:3559–3567
Bertholon I, Ponchel G, Labarre D, Couvreur P, Vauthier C (2006c) Bioadhesive properties of poly(alkylcyanoacrylate) nanoparticles coated with polysaccharide. J Nanosci Nanotechnol 6:3102–3109
Bertholon I, Vauthier C, Labarre D (2006b) Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide. Pharm Res 23:1313–1323. doi:10.1007/s11095-006-0069-0
Bot GM, Bot KG, Ogunranti JO, Onah JA, Sule AZ, Hassan I, Dung ED (2010a) The use of cyanoacrylate in surgical anastomosis: an alternative to microsurgery. J Surg Tech Case Rep 2:44–48. doi:10.4103/2006-8808.63727
Bouchemal K, Briançon S, Perrier E, Fessi H, Bonnet I, Zydowicz N (2004) Synthesis and characterization of polyurethane and poly(ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification. Int J Pharm 269:89–100
Boudad H, Legrand P, Lebas G, Cheron M, Duchêne D, Ponchel G (2001) Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir. Int J Pharm 218:113–124
Bravo-Osuna I, Vauthier C, Favabollini A, Palmieri GF, Ponchel G (2007b) Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 28:2233–2243
Bravo-Osuna I, Vauthier C, Ponchel G (2007a) Tuning of shell and core characteristics of chitosan decorated acrylic nanoparticles. Eur J Pharm Sci 30:143–154
Chauvierre C, Labarre D, Couvreur P, Vauthier C (2003a) Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles. Pharm Res 20:1786–1793
Chauvierre C, Labarre D, Couvreur P, Vauthier C (2003b) Plug-in spectrometry with optical fibers as a novel analytical tool for nanoparticles technology: application to the investigation of the emulsion polymerization of the alkylcyanoacrylate. J Nanoparticle Res 5:365–371
Chauvierre C, Labarre D, Couvreur P, Vauthier C (2003c) A radical emulsion polymerization of alkylcyanoacrylates initiated by the redox system dextran—cerium IV in acidic aqueous conditions. Macromolecules 36:6018–6027
Chauvierre C, Labarre D, Couvreur P, Vauthier C (2004) A new approach for the characterization of insoluble amphiphilic polymers based on their emulsifying properties. Colloid Polym Sci 282:1097–1104
Chouinard F, Buczkowski S, Lenaerts V (1994) Poly(alkylcyanoacrylate) nanocapsules: physicochemical characterization and mechanism of formation. Pharm Res 11:869–874
Cournarie F, Chéron M, Besnard M, Vauthier C (2004) Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules. Eur J Pharm Biopharm 57:171–179
Couvreur P, Kante B, Roland M, Guiot P, Baudhuin P, Speiser P (1979) Poly(cyanoacrylate) nanoparticles as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J Pharm Pharmacol 31:331–332
Couvreur P, Vauthier C (2006) Nanotechnology: intelligent design to treat complex disease. Pharm Res 23:1417–1450. doi:10.1007/s11095-006-0284-8
Damgé C, Michel C, Aprahamian M, Couvreur P (1988) New approach for oral administration of insulin with poly-alkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37:246–251
Damgé C, Vonderscher J, Marbach P, Pinget M (1997) Poly(alkylcyanoacrylate) nanocapsules as a delivery system in the rat for octeotride, a long-acting somatostoatin analogue. J Pharm Pharmacol 49:949–954
da Silveira Monza, Ponchel G, Puisieux F, Duchêne D (1998) Combined poly(isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs. Pharm Res 15:1051–1055
Douglas SJ, Illum L, Davis SS (1985) Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers. J Colloid Interface Sci 103:154–163
Dufour-Lamartinie JF, Habersetzer F, Abergel A, Merle P, Si Ahmed SN, Bonyhay L, Taieb J, Costantini D, Trepo C (2006) Phase 1 study of intra-arterial hepatic (iah) delivery of doxorubicin-transdrug® (dt) for patients with advanced hepatocellular carcinoma (hcc). J Clin Virol 36(Suppl 2):14094
Gallardo M, Couarraze G, Denizot B, Treupel L, Couvreur P, Puisieux F (1993) Study of the mechanism of formation of nanoparticles and nanocapsules of poly(isobutyl-2-cyanoacrylate). Int J Pharm 100:55–64. doi:10.1016/0378-5173(93)90075-Q
Gallardo MM, Roblot-Treupel L, Mahuteau J, Genin I, Couvreur P, Plat M, Puisieux F (1989) Nanocapsules et nanospheres d’alkylcyanoacrylate. Interaction principe actif-polymère. Abstract of the 5th international congres of pharmaceutical technology May 30 to June 1, 1989. APGI, Chatenay-Malabry, France, pp 36–45
Ganachaud F, Katz JL (2005) Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulisification as an alternative to ultrasonic and high-shear devices. Chem Phys chem. 6:209–216
Gasco MR, Trotta M (1986) Nanoparticles from microemulsions. Int J Pharm 29:267–268. doi:10.1016/0378-5173
Gate L, Vauthier C, Couvreur P, Tew KD, Tapiero H (2001) Glutathione loaded poly(isobutylcyanoacrylate) nanoparticles and liposomes: comparative effects in urine erythroleukemia and macrophage-like cells. STP Pharma Sci 11:355–361
Gautier JC, Grangier JL, Barbier A, Dupont P, Dussosoy D, Pastor G, Couvreur P (1992) Biodegradable nanoparticles for subcutaneous adminstration of growth hormone releasing factor (hGRF). J Control Rel 3:205–210
Grislain L, Couvreur P, Lenaerts V, Roland M, Deprez-Decampeneere D, Speiser P (1983) Pharmacokinetics and biodistribution of a biodegradable drug-carrier. Int J Pharm 15:335–345
Gross-Heitfeld C, Linders J, Appel R, Selbach F, Mayer C (2014) Polyalkylcyanoacrylate nanocapsules: variation of membrane permeability by chemical cross-linking. J Phys Chem B 118:4932–4939. doi:10.1021/jp5003098
Guize V, Drouin JY, Benoit J, Mahuteau J, Dumont P, Couvreur P (1990) Vidarabine-loaded nanoparticles: a physicochemical study. Pharm Res 7:736–741
Hansali F, Poisson G, Wu M, Bendedouch D, Marie E (2011) Miniemulsion polymerizations of n-butyl cyanoacrylate via two routes: towards a control of particle degradation. Coll Surf B Biointerf 88:332–338. doi:10.1016/j.colsurfb.2011.07.010
Hillaireau H, Le Doan T, Chacun H, Janin J, Couvreur P (2007) Encapsulation of mono-and oligo-nucleotides into aqueous-core nanocapsules in presence of various water soluble polymers. Int J Pharm 331:148–152. doi:10.1016/j.ijpharm.2006.10.031
Kattan J, Droz JP, Couvreur P, Marino JP, Boutan-Laroze A, Rougier P, Brault P, Vranckx H, Grognet JM, Morge X, Sancho-Garnier H (1992) Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles. Invest New Drugs 10:191–199
Kreuter J (2007) Nanoparticles–a historical perspective. Int J Pharm 331:1–10
Kulkarni RK, Bartak DE, Leonard F (1971) Initiation of polymerization of alkyl 2-cyanoacrylates in aqueous solutions of glycine and its derivatives. J Polym Sci A Polym Chem 9:2977–2981. doi:10.1002/pol.1971.150091018
Labarre D, Vauthier C, Chauvierre C, Petri B, Müller R, Chehimi MM (2005) Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. Biomaterials 26:5075–5084
Lambert G, Fattal E, Pinto-Alphandary H, Gulik A, Couvreur P (2000) Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Pharm Res 17:707–714. doi:10.1023/A:1007582332491
Landfester K (2003) Miniemulsions for nanoparticle synthesis. Top Curr Chem 227:75–123. doi:10.1007/b10835
Landfester K, Weiss C, Kubasch J (2007) Two step miniemulsion process. PCT/EP2007/056697 filed 3 July 2007, WO 2008003706 A1, 10 January 2008
Lenaerts V, Couvreur P, Christiaensleyh D, Joiris E, Roland M et al (1984) Degradation of poly(isobutylcyanoacrylate) nanoparticles. Biomaterials 5:65–68
Lescure F, Zimmer C, Roy D, Couvreur P (1992) Optimization of polyalkylcyanoacrylate nanoparticle preparation: Influence of sulfur dioxide and pH on nanoparticle characteristics. J Colloid Interface Sci 154:77–86
Limouzin C, Cavaggia A, Ganachaud F, Hemmery P (2003) Anionic polymerization of n-butyl cyanoacrylate in emulsion and miniemulsion. Macromolecules 36:667–674
Lira MC, Santos-Magalhães NS, Nicolas V, Marsaud V, Silva MP, Ponchel G, Vauthier C (2011) Cytotoxicity and cellular uptake of newly synthesized fucoidan-coated nanoparticles. Eur J Pharm Biopharm 79:162–170. doi:10.1016/j.ejpb.2011.02.013
Lowe PJ, Temple CS (1994) Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats. J Pharm Pharmacol 46:547–552
de Martimprey H, Bertrand JR, Malvy C, Couvreur P, Vauthier C (2010) New core-shell nanoparticules for the intravenous delivery of siRNA to experimental thyroid papillary carcinoma. Pharm Res 27:498–509. doi:10.1007/s11095-009-0043-8
Mitri K, Vauthier C, Huang N, Menas A, Ringard-Lefebvre C, Anselmi C, Stambouli M, Rosilio V, Vachon J-J, Bouchemal K (2012) Scale-up of nano-emulsion produced by emulsification and solvent diffusion. J Pharm Sci 101:4240–4247. doi:10.1002/jps.23291
Murthy RSR, Harivardhan R (2006) Poly(alkyl cyanoacrylate) nanoparticles for delivery of anti-cancer drugs, Chap 15. In: Amiji MM (ed) Nanotechnology for cancer therapy. Taylor & Francis Group, Boca Raton. doi:10.1201/9781420006636.ch15
Müller RH, Lherm C, Herbort J, Couvreur P (1990) In vitro model for the degradation of alkylcyanoacrylate nanoparticles. Biomaterials 11:590–595
Nemati F, Cavé GN, Couvreur P (1992) Lyophilization of substances with low water permeability by a modification of crystallized structures during freezing. In: Abstract of the 6th international congres of pharmaceutical technology, vol 3. 2–4 June 1992. APGI, Chatenay-Malabry, France, pp 487–93
Nicolas J, Couvreur P (2009) Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines. Nanomed Nanobiotechnol 1:111–127. doi:10.1002/wnan.15
Nicolas J, Mura S, Brambilla D, Mackiewicz N, Couvreur P (2013) Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem Soc Rev 42:1147–1235
Nicolas J, Vauthier C (2011) Poly(alkylcyanoacrylate) nanosystems. In: Prokov A (ed) Intracellular delivery: fundamentals and applications, fundamental biomedical technologies, vol 5. Springer Science+Business Madia B.V., Dordrecht, pp 225–251. doi:10.1007/978-94-007-1248-5_9
Page-Clisson M, Gibaud S, Pinto-Alphandary H, Weingarten C, Couvreur P (1998) Polyisobutylcyanoacrylate nanoparticles as drug carriers: influence of sulfur dioxide on the physico-chemical characteristics of ciprofloxacin-and doxorubicin-loaded nanoparticles. Int J Pharm 166:117–120
Peracchia MT, Vauthier C, Passirani C, Couvreur P, Labarre D (1997) Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. Life Sci 61:749–761
Puglisi G, Fresta M, Giammona G, Ventura CA (1995) Influence of the preparation conditions on poly(ethylcyanoacrylate) nanocapsule formation. Int J Pharm 125:283–287
Ramon AL, Bertrand JR, De Martimprey H, Bernard G, Ponchel G, Malvy C et al (2013) SiRNA associated with immunonanoparticles directed against cd99 antigen improve gene expression inhibition in vivo in Ewing’s sarcoma. J Mol Recognit 26:318–329
Rollot JM, Couvreur P, Roblot-Treupel L, Puisieux F (1986) Physicochemical and morphological characterization of polyisobutylcyanoacrylate nanocapsules. J Pharm Sci 75:361–364
Ryan B, McCann G (1996) Novel sub-ceiling temperature rapid depolymerization-repolymerization reactions of cyanoacrylate polymers. Macromol Rapid Commun 17:217–227
Schork FJ, Luo Y, Smulders W, Russum JP, Butté A, Fotenot K (2005) Miniemulsion polymerization. Adv Polym Sci 175:129–255
Seijo B, Fattal E, Roblot-Treupel L, Couvreur P (1990) Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading. Int J Pharm 62:1–7
Soma E, Atali P, Merle P (2012) A clinically relevant case study: the development of Livatag 1 for the treatment of advanced hepatocellular carcinoma, Chap 11. In: Alonso MJ, Csaba NS (eds) RSC drug discovery series no. 22 nanostructured biomaterials for overcoming biological barriers. The Royal Society of Chemistry, Cambridge, pp 591–600
Stumpo M, Anselmi C, Vauthier C, Mitri K, Hanno I, Huang N, Bouchemal K (2013) Scale-up of polyamide and polyester Parsol® MCX nanocapsules by interfacial polycondensation and solvent diffusion method. Int J Pharm 454:678–685. doi:10.1016/j.ijpharm.2013.06.062
Thioune O, Fessi H, Devissaguet JP, Puisieux F (1997) Preparation of pseudolatex by nanoprecipitation: influence of the solvent nature on intrinsic viscosity and interaction constant. Int J Pharm 146:233–238
Toub N, Bertrand JR, Tamaddon A, Elhamess H, Hillaireau H, Maksimenko A, Maccario J, Malvy C, Fattal E, Couvreur P (2006) Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma. Pharm Res 23:892–900
Varenne F, Botton J, Merlet C, Vachon JJ, Geiger S, Infante IC, Chehimi M, Vauthier C (2015) Standardization and validation of a protocol of zeta potential measurements by electrophoretic light scattering for nanomaterial characterization. Colloid Surf A Physicochem Eng Asp 486:218–231
Vauthier C, Bouchemal K (2009) Methods for the preparation and the manufacture of polymer nanoparticles. Pharm Res 26:1025–1058. doi:10.1007/s11095-008-9800-3
Vauthier C, Bouchemal K (2011) Processing and scale-up of polymeric nanoparticles. In: Prokop A (ed) Intracellular delivery: fundamentals and applications, fundamental biomedical technologies,vol 5, Springer Science+Business Media B.V., Dordrecht, pp 433–456. doi:10.1007/978-94-007-1248-5_16
Vauthier C, Cabane B, Labarre D (2008) How to concentrate nanoparticles and avoid aggregation? Eur J Pharm Biopharm 69:466–475. doi:10.1016/j.ejpb.2008.01.025
Vauthier C, Couvreur P (2002) Degradation of polycyanoacrylates. In: Matsumara JP, Steinbuchel A (eds) Handbook of biopolymers. Miscellaneous biopolymers and biodegradation of synthetic polymers, vol 9. Wiley, Weinheim, pp 457–490
Vauthier C, Labarre D, Ponchel G (2007) Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery. J Drug Target 15:641–663
Vauthier C, Persson B, Lindner P, Cabane B (2011) Protein adsorption and complement activation for di-block copolymer nanoparticles. Biomaterials 32:1646–1656. doi:10.1016/j.biomaterials.2010.10.026
Vauthier C (2015) Interactions of polysaccharide-coated nanoparticles with proteins, Chap 18. In: Sutariya VB, Pathak Y (eds) Biointeractions of nanomaterials. Taylor & Francis Group, Boca Raton, pp 365–382
Vauthier C, Zandanel C, Ramon AL (2013) Chitosan-based nanoparticles for in vivo delivery of interfering agents including siRNA. Curr Opion Colloid Interface Sci 18:406–418. doi:10.1016/j.cocis.2013.06.005
Vitale AS, Katz JL (2003) Liquid droplet dispersions formed by homogeneous liquid–liquid nucleation: “the Ouzo effect”. Langmuir 19:4105–4110
Vranckx H, Demoustier M, Deleers M (1996) A new nanocapsule formulation with hydrophilic core: application to the oral administration of salmon calcitonin in rats. J Pharm Pharmacol 42:345–347
Watnasirichaikul S, Davies NM, Rades R, Tucker IG (2000) Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharm Res 17:684–689
Watnasirichaikul S, Rades T, Tucker IG, Davies NM (2002) Effects of formulation variables on characteristics of poly(ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions. Int J Pharm 235:237–246
Weiss CK, Lorenz MR, Landfester K, Mailänder V (2007b) Cellular uptake behavior of unfunctionalized and functionalized PBCA particles prepared in a miniemulsion. Macromol Biosci 7:883–896
Weiss CK, Ziener U, Landfester K (2007a) A route to nonfunctionalized and functionalized poly(n-butylcyanoacrylate) nanoparticles: preparation in miniemulsion. Macromolecules 40:928–938. doi:10.1021/ma061865l
Wohlgemuth M, Mayer C (2003) Pulsed field gradient NMR on polybutylcyanoacrylate nanocapsules. J Colloid Interface Sci 260:324–331
Wu M, Dellacherie E, Durand A, Marie E (2009b) Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization (1): dextran-based surfactants. Colloids Surf B Biointerfaces 69:141–146. doi:10.1016/j.colsurfb.2008.12.010
Wu M, Dellacherie E, Durand A, Marie E (2009c) Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization. 2. PEG-based surfactants. Colloids Surf B Biointerfaces. 69:147–151. doi:10.1016/j.colsurfb.2008.10.003
Wu M, Frochot C, Dellacherie E, Marie E (2009a) Well-defined poly(butyl-cyanoacrylate) nanoparticles via miniemulsion polymerization. Macromol Symp 281:39–46
Wu M (2013) Synthèse de nanoparticules à propriétés de surface contrôlées par polymérisation en miniémulsion pour la vectorisation de molécules actives. Ph.D thesis. Institut National Polytechnique de Lorraine, Nancy, France 13 Dec 2013. http://docnum.univ-lorraine.fr/public/INPL/2007_WU_M.pdf. http://www.theses.fr/132140489. Accessed 2 Sept 2015
Zandanel C, Vauthier C (2012a) Poly(isobutylcyanoacrylate) nanoparticles decorated with chitosan: effect of conformation of chitosan chains at the surface on complement activation properties. J Colloid Sci Biotechnol 1:68–81
Zandanel C, Vauthier C (2012b) Characterization of fluorescent poly(isobutylcyanoacrylate) nanoparticles obtained by copolymerization of a fluorescent probe during Redox Radical Emulsion Polymerization (RREP). Eur J Pharm Biopharm 82:66–75. doi:10.1016/j.ejpb.2012.05.002
Zhang Y, Zhu S, Yin L, Gian F, Tang C, Yin C (2008) Preparation, characterization and biocompatibility of poly(ethylene glycol)-poly(n-butyl cyanoacrylate) nanocapsules with oil core via miniemulsion polymerization. Eur Polym J 44:1654–1662
Zimmer A (1999) Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers. Methods 18:286–295
Acknowledgments
CV addresses her warm thanks to Patrick Couvreur who has introduced her in the poly(alkylcyanoacrylate) nanoparticle world and for fruitful discussions that have been a source of inspiration for her work. CV also thanks Denis Labarre for the collaboration that has started at the drawn of the millennium and lasted up to his retirement in developing the radical emulsion polymerization of ACA that opened huge possibilities to design poly(alkylcyanoacrylate) nanoparticles giving them new properties needed to control their in vivo fate hence drug delivery potential. Thanks to all Ph.D. students, Post Doc, and colleagues around the world who have provided with new ideas of making poly(alkylcyanoacrylate) nanoparticles based on the polymerization of these very tricky monomers.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Vauthier, C. (2016). Methods for the Preparation of Nanoparticles by Polymerization. In: Vauthier, C., Ponchel, G. (eds) Polymer Nanoparticles for Nanomedicines. Springer, Cham. https://doi.org/10.1007/978-3-319-41421-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-41421-8_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41419-5
Online ISBN: 978-3-319-41421-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)